- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Total 4002 results
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Memorial Hospital of Rhode IslandNational Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Norwegian University of Science and TechnologyCompletedChronic Obstructive Pulmonary Disease (COPD)Norway
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
University of PennsylvaniaTerminatedChronic Obstructive Pulmonary Disease (COPD)United States
-
Chest Hospital, Ministry of Health and Welfare,...CompletedChronic Obstructive Pulmonary Disease (COPD)Taiwan
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)China, Philippines, Korea, Republic of, India
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Romania, Ukraine, Denmark, Netherlands, Canada
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
University of Sao PauloCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
King's College Hospital NHS TrustUniversity of BrightonCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University Hospital, GhentGlaxoSmithKline; University GhentCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Netherlands, Argentina, South Africa, Chile, Peru
-
Laval UniversityMaltais, Francois, M.D.; Saey, Didier, M.D.CompletedChronic Obstructive Pulmonary Disease (COPD)Canada
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Czechia, Hungary, Russian Federation
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Belgium, Canada, France, Germany, Italy, Netherlands, South Africa, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United States, Canada, India, Italy, Poland, South Africa
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Nuvaira, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)Netherlands, South Africa
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
-
University Medical Center GroningenTerminatedChronic Obstructive Pulmonary Disease (COPD)Netherlands
-
Air Liquide Santé InternationalITEC Services; Lincoln Medical and Mental Health CenterCompletedChronic Obstructive Pulmonary Disease (COPD)France, Spain, Germany, Italy
-
Aveiro UniversityFundação para a Ciência e a TecnologiaCompletedChronic Obstructive Pulmonary Disease (COPD)Portugal
-
Universidade Federal de PernambucoConselho Nacional de Desenvolvimento Científico e TecnológicoUnknownChronic Obstructive Pulmonary Disease (COPD)Brazil
-
Air Force Military Medical University, ChinaUnknownChronic Obstructive Pulmonary Disease (COPD)China
-
Pulmatrix Inc.Quotient ClinicalCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
University of EdinburghThe Dunhill Medical TrustCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Universidade Federal de Sao CarlosCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
Helse Stavanger HFCompletedChronic Obstructive Pulmonary Disease (COPD)Norway
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive | Chronic Obstructive Pulmonary Disease (COPD)Denmark, Germany, Netherlands, Finland, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Spain, Canada, Slovakia, India, Netherlands, Czech Republic, Hungary
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Russian Federation, Germany, Denmark, Italy, Canada, Czech Republic, Hungary, India, Slovakia, France, Colombia, Finland, Taiwan, Iceland, Peru
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Taiwan, Korea, Republic of, Japan, India, Hong Kong, Singapore
-
University of Nove de JulhoCompletedChronic Obstructive Pulmonary Disease (COPDBrazil
-
Organicell Regenerative MedicineSuspended
-
Jens Rikardt AndersenCompleted
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
KLOX Technologies Inc.CompletedModerate to Severe Chronic PeriodontitisCanada
-
Universitätsmedizin MannheimUnknownPulmonary Emphysema | COPD | Obstructive Ventilation DisorderGermany
-
Beaumont HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)Ireland
-
Imperial College LondonAstraZenecaWithdrawnCOPD Patients | Current Smokers | Healthy Non-smokersUnited Kingdom
-
Newcastle-upon-Tyne Hospitals NHS TrustAstraZeneca; Newcastle UniversityCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; University of Nottingham; Imperial College London; University... and other collaboratorsNot yet recruitingCOPD | COPD ExacerbationUnited Kingdom